A PHASE 1B DOSE ESCALATION EVALUATION OF SAFETY AND TOLERABILITY AND A PHASE 2 PROOF OF CONCEPT INVESTIGATION OF EFFICACY AND SAFETY OF ASP7317 FOR ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION: